Related Experiment Videos
Update on treatment regimens: prophylaxis versus on-demand therapy
1Department of Pediatrics, University of Colorado, Mountain States Regional Hemophilia and Thrombosis Center, Aurora, CO, USA.
Seminars in Hematology
|December 24, 2003
Summary
Routine clotting factor concentrate replacement (prophylaxis) prevents joint damage in hemophilia patients. However, low acceptance rates persist due to various barriers, necessitating further research into optimal regimens and adherence factors.
Area of Science:
- Hematology
- Pediatric Medicine
- Orthopedics
Background:
- Prophylaxis with clotting factor concentrate significantly reduces bleeding and prevents chronic joint disease in hemophilia.
- Despite proven benefits and international recommendations, prophylaxis adoption remains suboptimal in the hemophilia community.
- Current US data indicates that around 50% of severe hemophilia A and 33% of hemophilia B children receive prophylaxis.
Purpose of the Study:
- To review the effectiveness of prophylaxis in hemophilia management.
- To identify barriers to prophylaxis acceptance and adherence.
- To highlight areas for future research in hemophilia prophylaxis.
Main Methods:
- Literature review and synthesis of existing evidence on hemophilia prophylaxis.
- Analysis of factors influencing patient and family acceptance of prophylactic regimens.
- Identification of knowledge gaps and research needs in the field.
Main Results:
- Prophylaxis is highly effective in preventing hemarthrosis and long-term joint damage.
- Key barriers to prophylaxis include venous access issues, factor availability, injection therapy aversion, safety concerns, cost, and perceived lack of necessity.
- Significant inter-individual variability in bleeding patterns and joint damage progression exists, with optimal prophylaxis regimens and reversibility of joint damage still under investigation.
Conclusions:
- Prophylaxis is a cornerstone of modern hemophilia care, crucial for preventing disability.
- Addressing barriers to acceptance and adherence is essential for improving prophylaxis uptake.
- Future research should focus on understanding bleeding variability, joint damage predictors, optimal regimens, and factors influencing family adherence.